Your browser doesn't support javascript.
loading
Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.
Demchuk, Andrew M; Yue, Patrick; Zotova, Elena; Nakamya, Juliet; Xu, Lizhen; Milling, Truman J; Ohara, Tomoyuki; Goldstein, Joshua N; Middeldorp, Saskia; Verhamme, Peter; Lopez-Sendon, Jose Luis; Conley, Pamela B; Curnutte, John T; Eikelboom, John W; Crowther, Mark; Connolly, Stuart J.
Afiliación
  • Demchuk AM; Departments of Clinical Neurosciences and Radiology, Cumming School of Medicine, University of Calgary, AB, Canada (A.M.D.).
  • Yue P; Portola Pharmaceuticals, Inc, now Alexion Pharmaceuticals, Inc, South San Francisco, CA (P.Y., P.B.C., J.T.C.).
  • Zotova E; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.).
  • Nakamya J; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.).
  • Xu L; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.).
  • Milling TJ; Department of Neurology, Seton Dell Medical School Stroke Institute, Austin, TX (T.J.M.).
  • Ohara T; Department of Neurology, Kyoto Prefectural University of Medicine, Japan (T.O.).
  • Goldstein JN; Department of Emergency Medicine, Massachusetts General Hospital, Boston (J.N.G.).
  • Middeldorp S; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Meibergdreef, the Netherlands (S.M.).
  • Verhamme P; Center for Molecular and Vascular Biology, University of Leuven, Belgium (P.V.).
  • Lopez-Sendon JL; Department of Cardiology, Hospital Universitario La Paz, IdiPaz, Universidad Autonoma de Madrid, Spain (J.L.L.-S.).
  • Conley PB; Portola Pharmaceuticals, Inc, now Alexion Pharmaceuticals, Inc, South San Francisco, CA (P.Y., P.B.C., J.T.C.).
  • Curnutte JT; Portola Pharmaceuticals, Inc, now Alexion Pharmaceuticals, Inc, South San Francisco, CA (P.Y., P.B.C., J.T.C.).
  • Eikelboom JW; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.).
  • Crowther M; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.).
  • Connolly SJ; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.).
Stroke ; 52(6): 2096-2105, 2021 06.
Article en En | MEDLINE | ID: mdl-33966491
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Recombinantes / Factor Xa / Inhibidores de Factor de Coagulación Sanguínea / Hemorragias Intracraneales / Hemostasis Tipo de estudio: Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Stroke Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Recombinantes / Factor Xa / Inhibidores de Factor de Coagulación Sanguínea / Hemorragias Intracraneales / Hemostasis Tipo de estudio: Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Stroke Año: 2021 Tipo del documento: Article